中国现代神经疾病杂志 ›› 2019, Vol. 19 ›› Issue (11): 819-825. doi: 10.3969/j.issn.1672-6731.2019.11.004

• 专题讲座 • 上一篇    下一篇

2 胶质瘤侵袭迁移靶向治疗

李涛, 海龙, 杨学军   

  1. 300052 天津医科大学总医院神经外科
  • 收稿日期:2019-11-16 出版日期:2019-11-25 发布日期:2019-11-25
  • 通讯作者: 杨学军,Email:ydenny@126.com
  • 基金资助:

    国家自然科学基金资助项目(项目编号:81872063)

Targeted therapy on glioma migration and invasion

LI Tao, HAI Long, YANG Xue-jun   

  1. Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, China
  • Received:2019-11-16 Online:2019-11-25 Published:2019-11-25
  • Contact: YANG Xue-jun (Email: ydenny@126.com)
  • Supported by:

    This study was supported by the National Natural Science Foundation of China (No. 81872063).

摘要:

恶性胶质瘤是临床最为常见的原发性中枢神经系统肿瘤,属于难治性肿瘤之一,患者多预后不良。具有高度侵袭性的胶质瘤细胞可以逃避手术最大切除,以及同步放射治疗和药物化疗,是导致治疗难以奏效和复发的主要原因。回顾本实验室相关研究结果并结合文献,阐述胶质瘤侵袭迁移的相关分子机制及靶向治疗研究进展。

关键词: 神经胶质瘤, 肿瘤侵润, 细胞运动, 分子靶向治疗, 综述

Abstract:

Malignant glioma, one of the most lethal malignancies, is the most common primary central nervous system tumor with a dismal prognosis. The major obstacle to cure and recurrence is diffuse invasion, which enables glioma cells to escape complete surgical resection and radiotherapy and chemotherapy. Combined with findings in our lab and related articles, this review comprehensively elaborates the therapies target to glioma invasion and migration and relevant molecular mechanisms.

Key words: Glioma, Neoplasm invasiveness, Cell movement, Molecular targeted therapy, Review